- July 23, 2019
This is a public workshop sponsored by FDA’s Office of New Drugs. It is aimed to bring experts in the area of neurotoxicity biomarkers from academia and industry to get their perspective on the need of circulating and MR imaging biomarkers of CNS damage for their utility in preclinical toxicity studies.
FDA White Oak Campus, Building 31 - Great Room A, 10903 New Hampshire Ave., Silver Spring, MD 20903
Attending a Public Meeting
Please register at Eventbrite by 11:59 pm on July 21, 2019. Please register online at the following Eventbrite link:https://www.eventbrite.com/e/biomarkers-in-neurotoxicity-tickets-61595473720. Onsite check-in and registration will begin at 7:30am EST on July 23, 2019.
Entrance for the public meeting participants (non-FDA employees) is through Building 1. Please allow time for routine security checks, as procedures will be performed. For parking and security information, please refer to https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm.
If you require special accommodations due to a disability, please contact Tiara Watkins at Tiara.Watkins@fda.hhs.gov, or call (301) 796-0621, no later than July 12, 2019, at 4:00 pm EST.
This public meeting will be available for online viewing, on the day of the meeting, please select the following link to attend virtually attend the meeting: https://collaboration.fda.gov/bioneuro/
If you have never attended a Connect Pro event before, test your connection at https://collaboration.fda.gov/common/help/en/support/meeting_test.htm. To get a quick overview of the Connect Pro program, visit https://www.adobe.com/go/connectpro_overview.
- Biomarkers of Neurotoxicity Agenda (PDF - 154 KB)
|Biomarkers of Neurotoxicity Agenda||pdf (154.95 KB)|